Parma, Italy

Anna Maria Cantarelli

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 8 EPO patents. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2014-2021.


% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Anna Maria Cantarelli

Introduction

Anna Maria Cantarelli is a prominent inventor based in Parma, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for respiratory diseases. With a total of 3 patents to her name, her work has had a substantial impact on the treatment of inflammatory and obstructive airway diseases.

Latest Patents

Among her latest patents is a dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation. This formulation is particularly useful for treating inflammatory or obstructive airways diseases. Another notable patent involves a similar dry powder formulation, which details the process of preparation and therapeutic uses of the combination of corticosteroid and beta-adrenergic drugs.

Career Highlights

Anna Maria Cantarelli is currently associated with Chiesi Farmaceutici S.p.a., a company known for its innovative pharmaceutical solutions. Her work at Chiesi has allowed her to focus on developing effective treatments for respiratory conditions, contributing to the company's reputation in the pharmaceutical industry.

Collaborations

She has collaborated with notable coworkers, including Daniela Cocconi and Irene Pasquali, who have also contributed to advancements in the field of respiratory therapies.

Conclusion

Anna Maria Cantarelli's innovative work in the pharmaceutical industry, particularly in respiratory treatments, showcases her dedication to improving patient care. Her patents reflect her commitment to advancing medical science and enhancing therapeutic options for patients with airway diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…